The aim of the study was to study the association between daily coffee consumption and all-cause and cardiovascular disease (CVD) mortality, as well as major cardiovascular events. In a subset of participants who underwent cardiac magnetic resonance imaging, the association between regular coffee consumption and cardiac structure and function was also assessed.
The study included participants without clinical manifestations of cardiac pathology (468,629 people, age 56.2 ± 8.1 years, of which 44.2% were men), who, depending on the frequency of coffee consumption, were divided into 3 groups: non-coffee drinkers; from light to moderate consumption (0.5–3 cups per day); and high consumption (> 3 cups per day). It turned out that 22.1% did not drink coffee regularly, 58.4% drank from 0.5 to 3 cups per day and 19.5% drank > 3 cups per day. The analysis showed that, compared with non-coffee drinkers, light to moderate coffee consumption (0.5–3 cups per day) was associated with a lower risk of all-cause mortality [HR = 0.88, 95% confidence interval (CI): 0.83-0.92; P < 0.001] and CVD (HR = 0.83, 95% CI: 0.74–0.94; P = 0.006) and stroke (HR = 0.79, 95% CI: 0.63) –0.99, P = 0.037) after following the study participants for 11 years. Thus, coffee consumption up to three cups per day was associated with better cardiovascular outcomes, as well as better functional and structural state of the myocardium.
Eur J Prev Cardiol. 2022 May 6;29(6):982-991. doi: 10.1093/eurjpc/zwac008. PMID: 35048949.
Eur J Prev Cardiol. 2022 May 6;29(6):982-991. doi: 10.1093/eurjpc/zwac008. PMID: 35048949.
